Related references
Note: Only part of the references are listed.Low molecular weight fucoidan attenuates liver injury via SIRTI/AMPK/PGC1 alpha axis in db/db mice
Yuanyuan Zheng et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Catalase deletion promotes prediabetic phenotype in mice
Claire Heit et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
The single IGF-1 partial deficiency is responsible for mitochondrial dysfunction and is restored by IGF-1 replacement therapy
M. Olleros Santos-Ruiz et al.
GROWTH HORMONE & IGF RESEARCH (2017)
Endogenous catalase delays high-fat diet-induced liver injury in mice
Lingjuan Piao et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2017)
Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis
Xiaoyan Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Geraniol attenuates hydrogen peroxide-induced liver fatty acid alterations in male rats
Ahmet Ozkaya et al.
JOURNAL OF INTERCULTURAL ETHNOPHARMACOLOGY (2017)
Glycemic Control and Weight Outcomes for Exenatide Once Weekly Versus Liraglutide in Patients with Type 2 Diabetes: A 1-Year Retrospective Cohort Analysis
Carrie McAdam-Marx et al.
CLINICAL THERAPEUTICS (2016)
Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial
Mark M. Smits et al.
DIABETOLOGIA (2016)
Cytochrome P450-2E1 promotes aging-related hepatic steatosis, apoptosis and fibrosis through increased nitroxidative stress
Mohamed A. Abdelmegeed et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease
Huiting Gao et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2015)
Novel pathway for iron deficiency in pediatric non-alcoholic steatohepatitis
Diana Moya et al.
CLINICAL NUTRITION (2015)
Effects of Insulin Glargine and Liraglutide Therapy on Liver Fat as Measured by Magnetic Resonance in Patients With Type 2 Diabetes: A Randomized Trial
An Tang et al.
DIABETES CARE (2015)
Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study
Ali A. Rizvi et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
Regulation of catalase expression in healthy and cancerous cells
Christophe Glorieux et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Peroxiredoxin 2, glutathione peroxidase, and catalase in the cytosol and membrane of erythrocytes under H2O2-induced oxidative stress
S. Rocha et al.
FREE RADICAL RESEARCH (2015)
Association of Nonalcoholic Fatty Liver Disease (NAFLD) with Hepatocellular Carcinoma (HCC) in the United States From 2004 to 2009
Zobair M. Younossi et al.
HEPATOLOGY (2015)
Pattern and profile of chronic liver disease in acute on chronic liver failure
Zaigham Abbas et al.
HEPATOLOGY INTERNATIONAL (2015)
Mouse Models of Diet-Induced Nonalcoholic Steatohepatitis Reproduce the Heterogeneity of the Human Disease
Mariana Verdelho Machado et al.
PLOS ONE (2015)
Oxidative stress modulation in hepatitis C virus infected cells
Sonia A. Lozano-Sepulveda et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Non-alcoholic fatty liver disease: The diagnosis and management
Shehab M. Abd El-Kader et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Endoplasmic Reticulum Stress and Oxidative Stress in Cell Fate Decision and Human Disease
Stewart Siyan Cao et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Catalase expression in MCF-7 breast cancer cells is mainly controlled by PI3K/Akt/mTor signaling pathway
Christophe Glorieux et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Paraoxonase 1 and oxidative stress in paediatric non-alcoholic steatohepatitis
Sonal Desai et al.
LIVER INTERNATIONAL (2014)
Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease
Forouzan Faghihzadeh et al.
NUTRITION RESEARCH (2014)
SirT1 Regulation of Antioxidant Genes Is Dependent on the Formation of a FoxO3a/PGC-1α Complex
Yolanda Olmos et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Serum biomarkers in type 2 diabetic patients with non-alcoholic steatohepatitis and advanced fibrosis
Nathalie Carvalho Leite et al.
HEPATOLOGY RESEARCH (2013)
High Dietary Fat Selectively Increases Catalase Expression within Cardiac Mitochondria
Paul M. Rindler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
The relationship between oxidative stress and nonalcoholic fatty liver disease: Its effects on the development of nonalcoholic steatohepatitis
Fatma Ucar et al.
REDOX REPORT (2013)
Differential activation of catalase expression and activity by PPAR agonists: Implications for astrocyte protection in anti-glioma therapy
Nicholas K. H. Khoo et al.
REDOX BIOLOGY (2013)
Patients with Nonalcoholic Fatty Liver Disease (NAFLD) have Higher Oxidative Stress in Comparison to Chronic Viral Hepatitis
Amit Kumar et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2013)
Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress
S. Gomez-Zorita et al.
BRITISH JOURNAL OF NUTRITION (2012)
Differential effects of low-dose resveratrol on adiposity and hepatic steatosis in diet-induced obese mice
Su-Jung Cho et al.
BRITISH JOURNAL OF NUTRITION (2012)
Effects of resveratrol on the amelioration of insulin resistance in KKAy mice
Sifan Chen et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2012)
Cardioprotection from oxidative stress in the newborn heart by activation of PPARγ is mediated by catalase
Tao Chen et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis
Anabela P. Rolo et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Naga Chalasani et al.
HEPATOLOGY (2012)
The insulin-like growth factor (IGF) signaling axis and hepatitis C virus-associated carcinogenesis (Review)
Aldona Kasprzak et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease
Kyoko Nomura et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2012)
Oxidative Stress
Jean-Charles Preiser
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2012)
Resveratrol improves insulin signaling in a tissue-specific manner under insulin-resistant conditions only: in vitro and in vivo experiments in rodents
Wonyoung Kang et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
Resveratrol up-regulates hepatic uncoupling protein 2 and prevents development of nonalcoholic fatty liver disease in rats fed a high-fat diet
Morten Moller Poulsen et al.
NUTRITION RESEARCH (2012)
Fish oil improves lipid metabolism and ameliorates inflammation in patients with metabolic syndrome: Impact of nonalcoholic fatty liver disease
Mohammed M. H. Al-Gayyar et al.
PHARMACEUTICAL BIOLOGY (2012)
Attenuation of insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed rats
Pankaj K. Bagul et al.
PHARMACOLOGICAL RESEARCH (2012)
Vitamins B status and antioxidative defense in patients with chronic hepatitis B or hepatitis C virus infection
Chun-che Lin et al.
EUROPEAN JOURNAL OF NUTRITION (2011)
Reactive oxygen species downregulate catalase expression via methylation of a CpG Island in the Oct-1 promoter
Xiaoyuan Quan et al.
FEBS LETTERS (2011)
Peroxisome proliferator-activated receptor γ regulates angiotensin II-induced catalase downregulation in adventitial fibroblasts of rats
Weiwei Yang et al.
FEBS LETTERS (2011)
Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Losartan in the Treatment of Nonalcoholic Steatohepatitis in Humans: A 12-Month Randomized, Prospective, Open-Label Trial
Dawn M. Torres et al.
HEPATOLOGY (2011)
Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents The TONIC Randomized Controlled Trial
Joel E. Lavine et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice
Yehuda Kamari et al.
JOURNAL OF HEPATOLOGY (2011)
Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview
Monica Marra et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
2,4,6-Octatrienoic acid is a novel promoter of melanogenesis and antioxidant defence in normal human melanocytes via PPAR-γ activation
Enrica Flori et al.
PIGMENT CELL & MELANOMA RESEARCH (2011)
Human Fatty Liver Disease: Old Questions and New Insights
Jonathan C. Cohen et al.
SCIENCE (2011)
Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: Mechanisms and pathophysiological role
J. Aubert et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2011)
Genetic analysis of expression profile involved in retinoid metabolism in non-alcoholic fatty liver disease
An Afida Ashla et al.
HEPATOLOGY RESEARCH (2010)
High urinary excretion of lipid peroxidation-derived DNA damage in patients with cancer-prone liver diseases
Jagadeesan Nair et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis
Susan S. Baker et al.
PLOS ONE (2010)
Protection against reactive oxygen species by selenoproteins
Holger Steinbrenner et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2009)
Apoptosis and Cytokinesin Non-Alcoholic Steatohepatitis
Wing-Kin Syn et al.
CLINICS IN LIVER DISEASE (2009)
Epidemiology and Natural History of Non-Alcoholic Steatohepatitis
Curtis K. Argo et al.
CLINICS IN LIVER DISEASE (2009)
Association between hepatic steatosis and serum IGF1 and IGFBP-3 levels in a population-based sample
Henry Voelzke et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Could inflammatory markers help diagnose nonalcoholic steatohepatitis?
Giovanni Tarantino et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2009)
Mutual Dependence of Foxo3a and PGC-1α in the Induction of Oxidative Stress Genes
Yolanda Olmos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Peroxisome Proliferator-Activated Receptor-γ Agonists Promote Differentiation and Antioxidant Defenses of Oligodendrocyte Progenitor Cells
Antonietta Bernardo et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Neuronal PPARγ Deficiency Increases Susceptibility to Brain Damage after Cerebral Ischemia
Xiurong Zhao et al.
JOURNAL OF NEUROSCIENCE (2009)
Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis
Anna Wieckowska et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Adipose expression of catalase is regulated via a novel remote PPARγ-responsive region
Yosuke Okuno et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Resveratrol attenuates the expression of HMG-CoA reductase mRNA in hamsters
Il Jin Cho et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression
Kazuhiro Hasegawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Nuclear Factor E2-Related Factor 2-Dependent Myocardiac Cytoprotection Against Oxidative and Electrophilic Stress
Hong Zhu et al.
Cardiovascular Toxicology (2008)
Antioxidants and phase 2 enzymes in macrophages: Regulation by Nrf2 signaling and protection against oxidative and electrophilic stress
Hong Zhu et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2008)
Foxo3a Inhibits Cardiomyocyte Hypertrophy through Transactivating Catalase
Wei-Qi Tan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Age-related differences in insulin-like growth factor-1 receptor signaling regulates Akt/FOXO3a and ERK/Fos pathways in vascular smooth muscle cells
Muyao Li et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet
Jiyun Ahn et al.
JOURNAL OF HEPATOLOGY (2008)
Exercise training promotes SIRT1 activity in aged rats
Nicola Ferrara et al.
REJUVENATION RESEARCH (2008)
Dramatic down-regulation of oxidoreductases in human hepatocellular carcinoma hepG2 cells: proteomics and gene ontology unveiling new frontiers in cancer enzymology
Lambert C. M. Ngoka
PROTEOME SCIENCE (2008)
Evaluation of blood oxidative stress-related parameters in alcoholic liver disease and non-alcoholic fatty liver disease
S. K. Das et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2008)
Catalase takes part in rat liver mitochondria oxidative stress Defense
Mauro Salvi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways
Kazuhiko Koike
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Catalase overexpression attenuates angiotensinogen expression and apoptosis in diabetic mice
M.-L. Brezniceanu et al.
KIDNEY INTERNATIONAL (2007)
IL-6 and IGF-1 are independent prognostic factors of liver steatosis and non-alcoholic steatohepatitis in morbidly obese patients
David Garcia-Galiano et al.
OBESITY SURGERY (2007)
Growth hormone reverses nonalcoholic steatohepatitis in a patient with adult growth hormone deficiency
Yutaka Takahashi et al.
GASTROENTEROLOGY (2007)
Nonalcoholic fatty liver disease in severely obese subjects
Pierre M. Gholam et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Cardiac-specific overexpression of catalase prolongs lifespan and attenuates ageing-induced cardiomyocyte contractile dysfunction and protein damage
Shan Wu et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2007)
Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2
John Willy Haukeland et al.
JOURNAL OF HEPATOLOGY (2006)
Total serum insulin-like growth factor-1 and C-reactive protein in metabolic syndrome with or without diabetes
Georgios Efstratiadis et al.
ANGIOLOGY (2006)
Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent it
K Begriche et al.
MITOCHONDRION (2006)
Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis
S Abiru et al.
LIVER INTERNATIONAL (2006)
The octamer binding transcription factor Oct-1 is a stress sensor
D Tantin et al.
CANCER RESEARCH (2005)
Insulin resistance: A metabolic pathway to chronic liver disease
E Bugianesi et al.
HEPATOLOGY (2005)
CCAAT/enhancer binding protein-β (C/EBP-β), a pivotal regulator of the TATA-less promoter in the rat catalase gene
M Taniguchi et al.
FEBS LETTERS (2005)
Increase in liver antioxidant enzyme activities in non-alcoholic fatty liver disease
G Perlemuter et al.
LIVER INTERNATIONAL (2005)
Role of Nrf2 signaling in regulation of antioxidants and phase 2 enzymes in cardiac fibroblasts: Protection against reactive oxygen and nitrogen species-induced cell injury
H Zhu et al.
FEBS LETTERS (2005)
NASH: a mitochondrial disease
D Pessayre et al.
JOURNAL OF HEPATOLOGY (2005)
A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease
E Bugianesi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1α
S Nemoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease
Z Yesilova et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms
E Bugianesi et al.
DIABETOLOGIA (2005)
Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management
P Portincasa et al.
CLINICAL BIOCHEMISTRY (2005)
Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: Results from the Third National Health and Nutrition Survey (NHANES III)
S Liangpunsakul et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2005)
Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population
LS Szczepaniak et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients
LA Videla et al.
CLINICAL SCIENCE (2004)
Catalase transgenic mice: characterization and sensitivity to oxidative stress
XL Chen et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2004)
Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury
YS Ho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Role of the liver in the control of carbohydrate and lipid homeostasis
C Postic et al.
DIABETES & METABOLISM (2004)
Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes
U Özcan et al.
SCIENCE (2004)
Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery
C Beymer et al.
ARCHIVES OF SURGERY (2003)
The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice
AM Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis
R Sreekumar et al.
HEPATOLOGY (2003)
Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients
HP Kopp et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes
JJ Senn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
G Marchesini et al.
HEPATOLOGY (2003)
A strategy for the ubiquitous overexpression of human catalase and CuZn superoxide dismutase genes in transgenic mice
XL Chen et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2003)
Reduction of pressor response to vasoconstrictor agents by overexpression of catalase in mice
H Yang et al.
AMERICAN JOURNAL OF HYPERTENSION (2003)
Macular edema reflects generalized vascular hyperpermeability in type 2 diabetic patients with retinopathy
ST Knudsen et al.
DIABETES CARE (2002)
Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter
GD Girnun et al.
MOLECULAR ENDOCRINOLOGY (2002)
Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study
MS Sandhu et al.
LANCET (2002)
Liver pathology in morbidly obese patients undergoing Roux-en-U gastric bypass surgery
PM Gholam et al.
OBESITY SURGERY (2002)
Metformin in non-alcoholic steatohepatitis
G Marchesini et al.
LANCET (2001)
Nonalcoholic fatty liver disease - A feature of the metabolic syndrome
G Marchesini et al.
DIABETES (2001)
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus
AD Pradhan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Nonalcoholic fatty liver disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese
JB Dixon et al.
GASTROENTEROLOGY (2001)
Are there predictive factors of severe liver fibrosis in morbidly obese patients with non-alcoholic steatohepatitis?
J Crespo et al.
OBESITY SURGERY (2001)
Increase in the concentration of carbon 18 monounsaturated fatty acids in the liver with hepatitis C: Analysis in transgenic mice and humans
K Moriya et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetes
JC Pickup et al.
LIFE SCIENCES (2000)
CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis
IA Leclercq et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
